Plk is a serine/threonine kinase, which was firstly identified in Drosophila as Polo mutant over 27 years ago (Sunkel & Glover, 1988) . This kinase is well conserved from budding yeast (Cdc5) to Drosophila (polo), Xenopus (Plxs) and mammals (Plks) (de Carcer et al., 2011a) . In mammalian cells, it has been reported that four Plk family members, from Plk1 to Plk4, are expressed and recently Plk5 has been characterized in the mouse and human cells (de Carcer et al., 2011a) . Plks are key regulators for various cellular events during cell division including centrosome maturation, DNA checkpoint activation, mitotic entry, spindle assembly, and cytokinesis ( Fig. 1) (Glover et al., 1998; Dai, 2005; Strebhardt & Ullrich, 2006 ).
Plk1 has a crucial role in the regulation of mitotic checkpoints. Hence, overexpression of this kinase causes overriding checkpoints, which can lead to immature cell division with aneuploidy, a hallmark of cancer (Kops et al., 2005) . Plk1 overexpression contributes to cancer development by promoting excessive cell proliferation through the misregulation of check point functions (Degenhardt & Lampkin, 2010) . Furthermore, Plk2 and Plk3 also have a relationship with p53 and are activated by DNA damage in mitosis, whereas Plk1 is inhibited (Jang et al., 2007) . Plk2 is a direct transcriptional target of p53 and Plk3-mediated is known as involved in neuron differentiation.
phosphorylation of p53 at Ser-20 is reported to stabilize p53 (Xie et al., 2001; Burns et al., 2003 Plk genes of which Plk1 is most similar to Drosophila polo (Ohkura et al., 1995) . Plk2 (also known as SNK) localizes at the centrosomes and plays a role in the entry into S phase (de Carcer et al., 2011a) . Inhibition of Plk2 resulted in formation of aberrant number of centrioles (Warnke et al., 2004) . Plk3 (also named FNK or PRK) is required at the G1-S phase transition and for DNA replication (Zimmerman & Erikson, 2007) . Plk4 (also known as SAK23) is found in all animals and it acts as a critical regulator of centriole duplication both in Drosophila and mammals (KleyleinSohn et al., 2007) . Both the mouse and human Plk5 genes encode proteins, however, to some extent they are different that the mouse Plk5 contains a complete kinase domain and PBD, while the human Plk5 encloses only a small portion of the kinase domain along with one PBD (de Carcer et al., 2011b) .
Mammalian Plks are required for the functional maturation of centrosomes and the assembly of a bipolar spindle. Microinjection of Plk1-specific antibody resulted in abnormal chromatin and microtubules, and hence in block of cell division (Lane & Nigg, 1996) . These results were derived from small, unseparated centrosome. Shortly before the onset of mitosis, the size and number of centrosomes increase and they are required for organizing the microtubules (Karsenti et al., 1984) . Through recent studies, γ-tubulin is thought to be a critical element in centrosomal microtubule nucleation during late G2/early prophase (Shu & Joshi, 1995; Sunkel et al., 1995) . Plk1 depletion or inhibition prevented the recruitment of γ-tubulin to centrosomes (Lane & Nigg, 1996; Haren et al., 2009 ). In addition, the accumulation of MPM-2 reactivity at centrosomes is inhibited in Plk1-injectied cells (Lane & Nigg, 1996) .
In the previous study, it has been shown that the removal of centrosomes from mammalian cells in culture prevented every part of features of mitosis, including the activation of Cdc2 kinase (Maniotis & Schliwa, 1991) .
Cdc25C is an activator of Cdc2 kinase and dephosphorylates and activates the CyclinB-Cdc2 complex shortly before the entry into the mitosis. Both the DNA damage and DNA replication checkpoints regulate CyclinB-Cdc2 activation partly through Cdc25C. Plx1, Xenopus homolog of Plk, can phosphorylate and activate Cdc25C in vitro. In
Xenopus oocyte maturation, Plx1 is activated in vivo with the same kinetics as Cdc25C (Qian et al., 1998 (Qian et al., 1998) . These studies demonstrated that Plx1 plays important roles both in the activation of Cdc25C in the mitosis as well as in meiosis.
Through in vitro study in mammalian cells and Drosophila system, it has been known that Plk1 is required for important steps in the onset and completion of mitosis, such as bipolar spindle assembly, segregation of chromosomal DNA (Ohkura et al., 1995) , centrosome maturation (Lane & Nigg, 1996) In mouse, depletion of Plk2 impairs embryonic growth and normal placental development resulted from decreased cell proliferation (Ma et al., 2003) .
Plk3 is also a key regulator of cell cycles during mitosis. It has been well known that Plk1 expression increased in various cancer tissues such as non small cell lung cancer (Wolf et al., 1997) , squamous cell carcinoma of the head and neck (Knecht et al., 1999) , esophageal cancer, gastric cancer (Tokumitsu et al., 1999) and colorectal cancer (Macmillan et al., 2001 ). In Plk1 siRNA-treated HeLa cells, the cell proliferation was dramatically inhibited whereas the cell viability decreased . Especially, apoptosis was induced in Plk1-depleted cancer cells ). These results demonstrate that Plk1 is related to the causes of cancer such as abnormal centrosome formation with abnormal cell cycles and apoptosis.
It is well known that centrosomes are critical in causing Plk1 is also associates with apoptosis. Fas-associated death domain-containing protein (FADD) was identified as a first adapter molecule that bridges the Fas-receptor during apoptosis (Peter et al., 1999) . The phosphorylation of FADD serves as a critical marker for the human cancer diagnosis (Shimada et al., 2005) . Plk1 phosphorylates FADD at Ser-194 in response to taxol treatment and is regulated through a negative feedback loop by its substrate, FADD (Jang et al., 2011) . In addition, Plk1 binds to the major 
